「news一般製品2022年10月20日」の検索結果
174件：141～145件目を表示
-
Mytear PINT CARE EX Mild | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines Mytear® PINT CARE EX Mild For eyestrain and blurred vision CHARACTERISTICS Contains the maximum concentration* of neostigmine methylsulfate with a focus adjustment-improving e
http://www.senju.co.jp/english/products/mytearpintcaremild.html -
NewMytear CL Vitaclear Cool | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines New Mytear® CL Vitaclear Cool Relieves tired eyes after intense use Before using eye drops while wearing soft contact lenses, check the instructions on the box and package ins
https://www.senju.co.jp/english/products/mytearvc.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye
https://www.senju.co.jp/english/rd/pipeline.html -
Research and Development System | Research & Development | SENJU Pharmaceutica
All things in nature have a reason for being. Today’s common sense is not common sense tomorrow. This is our motto. Senju Pharmaceutical has unique research systems, such as international joint resear
http://www.senju.co.jp/english/rd/about/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
http://www.senju.co.jp/english/rd/trial.html